Sinopharm Group Co. Ltd. (FRA:X2S1)

Market Cap	5.50B -19.2%
Revenue (ttm)	73.70B -0.7%
Net Income	914.01M +4.1%
EPS	0.29 +4.0%
Shares Out	n/a
PE Ratio	6.02
Forward PE	5.58
Dividend	0.34 (3.77%)
Ex-Dividend Date	Jun 24, 2026

Volume	n/a
Open	8.65
Previous Close	8.85
Day's Range	8.65 - 8.65
52-Week Range	8.65 - 11.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 94,910
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: X2S1

Financial Performance

In 2025, Sinopharm Group's revenue was 575.17 billion, a decrease of -1.60% compared to the previous year's 584.51 billion. Earnings were 7.16 billion, an increase of 1.50%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error